EXAS

43.04

7.07% -3.31

Dopo l'orario di chiusura: 43.04

Exact Sciences Corp (EXAS)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$46.35

Aprire:

$45.31

Volume 24 ore:

3.17M

Relative Volume:

1.52

Capitalizzazione di mercato:

$8.01B

Reddito:

$2.69B

Utile/perdita netta:

$-214.04M

Rapporto P/E:

-36.79

EPS:

-1.17

Flusso di cassa netto:

$98.43M

1 W Prestazione:

-7.64%

1M Prestazione:

-14.85%

6M Prestazione:

-34.28%

1 anno Prestazione:

-29.48%

Intervallo 1D:

$42.06

$45.73

Intervallo di 1 settimana:

$42.06

$47.94

Portata 52W:

$40.62

$79.62

Exact Sciences Corp Stock (EXAS) Company Profile

Nome

Exact Sciences Corp

Settore

Healthcare (1191)

Industria

Diagnostics & Research (61)

Telefono

608-284-5700

Indirizzo

5505 ENDEAVOR LANE, MADISON, WI

Dipendente

6,600

Cinguettio

@exactsciences

Prossima data di guadagno

2024-11-05

Ultimi documenti SEC

EXAS's Discussions on Twitter

Confronta EXAS con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
EXAS Exact Sciences Corp	43.04	8.01B	2.69B	-214.04M	98.43M	-1.17
TMO Thermo Fisher Scientific Inc	509.15	194.04B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	204.12	146.36B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	117.30	33.96B	6.53B	1.26B	1.31B	4.35
IDXX Idexx Laboratories Inc	406.29	33.45B	3.90B	887.87M	798.08M	10.67
IQV Iqvia Holdings Inc	181.41	32.16B	15.41B	1.37B	2.11B	7.50

Exact Sciences Corp Stock (EXAS) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-23	Iniziato	Barclays	Overweight
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-06-27	Iniziato	Scotiabank	Sector Outperform
2024-06-03	Ripresa	Jefferies	Buy
2024-01-02	Aggiornamento	The Benchmark Company	Hold → Buy
2023-12-14	Iniziato	Guggenheim	Buy
2023-12-13	Iniziato	Wolfe Research	Outperform
2023-10-10	Aggiornamento	Piper Sandler	Neutral → Overweight
2023-09-28	Iniziato	Bernstein	Outperform
2023-08-02	Downgrade	The Benchmark Company	Buy → Hold
2023-05-10	Aggiornamento	Craig Hallum	Hold → Buy
2023-05-05	Iniziato	UBS	Neutral
2023-03-09	Aggiornamento	Citigroup	Neutral → Buy
2023-02-10	Downgrade	Credit Suisse	Outperform → Neutral
2023-01-18	Downgrade	Raymond James	Outperform → Mkt Perform
2022-10-19	Downgrade	Craig Hallum	Buy → Hold
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-06-03	Iniziato	Piper Sandler	Neutral
2021-11-03	Downgrade	Raymond James	Strong Buy → Outperform
2021-07-29	Reiterato	BTIG Research	Buy
2021-07-29	Reiterato	Canaccord Genuity	Buy
2021-07-29	Reiterato	Oppenheimer	Outperform
2021-07-29	Reiterato	Stifel	Buy
2021-06-15	Iniziato	Raymond James	Strong Buy
2021-06-03	Iniziato	Goldman	Buy
2021-05-25	Iniziato	Wells Fargo	Equal Weight
2021-01-28	Iniziato	Truist	Buy
2020-10-29	Downgrade	UBS	Buy → Neutral
2020-10-28	Downgrade	Citigroup	Buy → Neutral
2020-10-08	Ripresa	BTIG Research	Buy
2020-04-02	Iniziato	Evercore ISI	Outperform
2020-01-10	Ripresa	BTIG Research	Buy
2020-01-07	Iniziato	Citigroup	Buy
2019-12-13	Iniziato	Dougherty & Company	Buy
2019-11-15	Iniziato	Stifel	Buy
2019-10-17	Reiterato	BofA/Merrill	Buy
2019-10-01	Ripresa	Craig Hallum	Buy
2019-09-26	Iniziato	Oppenheimer	Outperform
2019-02-26	Aggiornamento	Goldman	Neutral → Buy
2018-10-09	Iniziato	UBS	Buy
2018-09-05	Ripresa	The Benchmark Company	Hold
2018-08-13	Reiterato	Canaccord Genuity	Buy
2018-04-03	Aggiornamento	BTIG Research	Neutral → Buy
2018-01-29	Iniziato	Goldman	Neutral
2018-01-08	Reiterato	The Benchmark Company	Buy
2017-11-13	Downgrade	Robert W. Baird	Outperform → Neutral
2017-11-01	Downgrade	BTIG Research	Buy → Neutral

Mostra tutto

Exact Sciences Corp Borsa (EXAS) Ultime notizie

11:36 AM

Commit To Buy EXACT Sciences At $30, Earn 14% Using Options - Nasdaq

11:36 AM

09:02 AM

Expert Outlook: Exact Sciences Through The Eyes Of 7 Analysts - Benzinga

09:02 AM

07:05 AM

PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis - Business Wire

07:05 AM

Mar 12, 2025

Exact Sciences initiated with a Sector Perform at RBC Capital - TipRanks

Mar 12, 2025

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner - Joplin Globe

Mar 12, 2025

New Data Highlight the Positive Impact of Exact Sciences’ Oncotype DX - Business Wire

Mar 12, 2025

Mar 11, 2025

Charles Schwab Investment Management Inc. Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Mar 11, 2025

Exact Sciences Co. (NASDAQ:EXAS) Stake Increased by Jones Financial Companies Lllp - Defense World

Mar 11, 2025

Mar 07, 2025

3 Top Cancer Biotechs to Keep An Eye On in 2025 - Yahoo Finance

Mar 07, 2025

Mar 06, 2025

Exact Sciences at Raymond James Conference: Strategic Growth and Innovation - Investing.com

Mar 06, 2025

Cancer Biomarkers Research Report 2024: Global Market Projected to Soar to USD 62.14 Billion by 2034, Driven by Technological Advancements and Increasing Demand for Early Detection - GlobeNewswire Inc.

Mar 06, 2025

Mar 05, 2025

La Paloma CC: Set to host PGA Tour Champions' Cologuard Classic - The First Call

Mar 05, 2025

Mar 04, 2025

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS) - Yahoo Finance

Mar 04, 2025

Mar 03, 2025

Exact Sciences Corporation (EXAS): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey

Mar 03, 2025

Truist Financial Corp Sells 1,905 Shares of Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Mar 03, 2025

Mar 02, 2025

Exact Sciences Co. (NASDAQ:EXAS) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 02, 2025

Mar 01, 2025

EXACT Sciences Corp. to Host Earnings Call - ACCESS Newswire

Mar 01, 2025

Exact Sciences Co. (NASDAQ:EXAS) Shares Sold by New York State Common Retirement Fund - MarketBeat

Mar 01, 2025

Atria Wealth Solutions Inc. Takes $316,000 Position in Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Mar 01, 2025

Heritage Investors Management Corp Has $4.29 Million Stake in Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Mar 01, 2025

Feb 28, 2025

Generali Investments Towarzystwo Funduszy Inwestycyjnych Acquires 6,000 Shares of Exact Sciences Co. (NASDAQ:EXAS) - MarketBeat

Feb 28, 2025

Exact Sciences Co. (NASDAQ:EXAS) Shares Acquired by Sanctuary Advisors LLC - Defense World

Feb 28, 2025

Feb 27, 2025

Exact Sciences (NASDAQ:EXAS) Price Target Cut to $70.00 by Analysts at Piper Sandler - MarketBeat

Feb 27, 2025

Healthcare Spotlight: Exact Sciences Takes Center Stage at Two Major March Conferences - StockTitan

Feb 24, 2025

symbol__ Stock Quote Price and Forecast - CNN

Feb 24, 2025

Feb 23, 2025

Exact Sciences Stock Climbs After Strong Q2 Results - MSN

Feb 23, 2025

Feb 22, 2025

Bank of America Has Lowered Expectations for Exact Sciences (NASDAQ:EXAS) Stock Price - Defense World

Feb 22, 2025

Exact Sciences Reports Strong Revenue Growth in 2024 - TipRanks

Feb 22, 2025

Feb 21, 2025

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday? - Benzinga

Feb 21, 2025

Feb 20, 2025

Exact Sciences Corp Earnings Call Highlights Growth - TipRanks

Feb 20, 2025

Exact Sciences Earnings: Guidance at the Low End of Our Expectations, but Shares Remain Attractive - Morningstar

Feb 20, 2025

Exact Sciences Has an Established Colon Cancer Screening Franchise and a Progressing Pipeline - Morningstar

Feb 20, 2025

TD Cowen sees upside in Exact Sciences stock, maintains $86 target - Investing.com

Feb 20, 2025

Exact Sciences stock price target cut to $65 at BTIG - Investing.com India

Feb 20, 2025

Exact Sciences Corporation (NASDAQ:EXAS) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 20, 2025

Exact Sciences stock price target cut to $65 at BTIG By Investing.com - Investing.com South Africa

Feb 20, 2025

EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y - Yahoo Finance

Feb 20, 2025

Exact Sciences Reports Robust Q4 Earnings, Surpassing Revenue ProjectionsNews and Statistics - IndexBox, Inc.

Feb 20, 2025

Exact Sciences (EXAS) PT Lowered to $65 at BTIG - StreetInsider.com

Feb 20, 2025

Exact Sciences: Q4 Earnings Snapshot - mySA

Feb 20, 2025